In vitro expansion of CD34+ CD38- cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia

Leukemia

Volumn 29, Issue 3, 2015, Pages 606-614

  Sakashita, K ^a   Kato, I ^b   Daifu, T ^b   Saida, S ^b   Hiramatsu, H ^b   Nishinaka, Y ^c   Ebihara, Y ^d   Ma, F ^d,e   Matsuda, K ^f   Saito, S ^a   Hirabayashi, K ^a   Kurata, T ^a   Uyen, L T N ^a   Nakazawa, Y ^a   Tsuji, K ^d,g   Heike, T ^b   Nakahata, T ^c   Koike, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e INSTITUTE OF BLOOD TRANSFUSION   (China)

^f SHINSHU UNIVERSITY HOSPITAL   (Japan)

^g Shinshu Ueda Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; RECOMBINANT THROMBOPOIETIN; STEM CELL FACTOR RECEPTOR; THROMBOPOIETIN RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANOSINE TRIPHOSPHATASE; KRAS PROTEIN, HUMAN; MEMBRANE PROTEIN; NRAS PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; PTPN11 PROTEIN, HUMAN; RAS PROTEIN;

AGM S3 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER STEM CELL; CELL PROLIFERATION; CELL STIMULATION; CLONOGENESIS; CONTROLLED STUDY; CRYOPRESERVATION; ERYTHROID CELL; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; JUVENILE MYELOMONOCYTIC LEUKEMIA; KARYOTYPE; MOUSE; MS 5 CELL; NONHUMAN; ONCOGENE RAS; OP9 CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTPN11 GENE; STEM CELL EXPANSION; STROMA CELL; TUMOR GENE; ADOLESCENT; ANIMAL; CELL CLONE; COCULTURE; DRUG EFFECTS; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TRANSPLANTATION;

ADOLESCENT; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; CELL PROLIFERATION; CLONE CELLS; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GTP PHOSPHOHYDROLASES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MUTATION; NEOPLASTIC STEM CELLS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 84924373043     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.239     Document Type: Article

References (18)

1. Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008; 141: 567-575.
2. Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol 2011; 152: 677-687.
3. Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 2013; 45: 937-941.
4. Sawai N, Koike K, Higuchi T, Ogami K, Oda M. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia. Blood 1998; 91: 4065-4073.
5. Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N et al. Identi fication of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 1996; 88: 2655-2664.
6. Xu MJ, Tsuji K, Ueda T, Mukouyama YS, Hara T, Yang FC et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood 1998; 92: 2032-2040.
7. Ma F, Kambe N, Wang D, Shinoda G, Fujino H, Umeda K et al. Direct development of functionally mature tryptase/chymase double-positive connective tissue-type mast cells from primate embryonic stem cells. Stem Cells 2008; 26: 706-714.
8. Matsuda K, Sakashita K, Taira C, Tanaka-Yanagisawa M, Yanagisawa R, Shiohara M et al. Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia. Br J Haematol 2010; 148: 593-599.
9. Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S et al. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J Clin Invest 2001; 108: 1195-1204.
10. Sawai N, Koike K, Ito S, Mwamtemi HH, Kurokawa Y, Kinoshita T et al. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture. Blood 1999; 93: 509-518.
11. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182.
12. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood 2003; 102: 873-880.
13. Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959-963.
14. Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood 2007; 109: 5477-5480.
15. Matsuda K, Matsuzaki S, Miki J, Hidaka E, Yanagisawa R, Nakazawa Y et al. Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset. Leukemia 2006; 20: 485-490.
16. Matsuda K, Yoshida N, Miura S, Nakazawa Y, Sakashita K, Hyakuna N et al. Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations. Br J Haematol 2012; 157: 647-650.
17. Yoshida N, Yagasaki H, Xu Y, Matsuda K, Yoshimi A, Takahashi Y et al. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia. Pediatr Res 2009; 65: 334-340.
18. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002; 16: 1992-2003.